Largest Breast Cancer Organization Investing $60 Million to Research Despite Down Economy
SAN FRANCISCO, April 9 /PRNewswire-USNewswire/ -- Testing whether a powerful ingredient in marijuana can help slow the growth of aggressive breast cancer cells is just one of six Bay Area breast cancer studies being funded this year by Susan G. Komen for the Cure(R), the global leader in the breast cancer movement announced today.
The projects are part of a $60 million portfolio of 2009 research grants that Komen for the Cure is investing with scientists worldwide to find the cures for breast cancer.
"Breast cancer doesn't care about the economy, and with more than 1.3 million new cases of breast cancer expected this year, the need for new research is more urgent than ever," said Hala Moddelmog, Komen's CEO and president.
In the Bay Area this year, Komen's $1.8 million in grants will go to the
The UCSF study will try to improve bilingual communication and education between Latinas and their health care providers. One Stanford grant, if successful, could reverse some of the debilitating neurological and cognitive side effects of brain metastases, halt the progression of disease and possibly reduce mortality. And CPMC researchers will test whether cannabidiol - an ingredient in marijuana - can inhibit the aggressive growth of some breast cancers.
"Komen's infusion of millions of dollars into research projects means that promising research that is designed to treat and ultimately eradicate breast cancer will continue," said Eric Winer, M.D., Komen's chief scientific advisor.
During the past 27 years, Komen has invested $400 million to fund research globally
'/>"/>
| SOURCE Copyright©2009 PR Newswire. All rights reserved |